APA (7th ed.) Citation

Rehab Abdelmonem, Inas Essam Ibrahim Al-Samadi, Rasha M. El Nashar, Bhaskara R. Jasti, & Mohamed A. El-Nabarawi. (2022). Fabrication of nanostructured lipid carriers ocugel for enhancing Loratadine used in treatment of COVID-19 related symptoms: Statistical optimization, in-vitro, ex-vivo, and in-vivo studies evaluation. Taylor & Francis Group.

Chicago Style (17th ed.) Citation

Rehab Abdelmonem, Inas Essam Ibrahim Al-Samadi, Rasha M. El Nashar, Bhaskara R. Jasti, and Mohamed A. El-Nabarawi. Fabrication of Nanostructured Lipid Carriers Ocugel for Enhancing Loratadine Used in Treatment of COVID-19 Related Symptoms: Statistical Optimization, In-vitro, Ex-vivo, and In-vivo Studies Evaluation. Taylor & Francis Group, 2022.

MLA (9th ed.) Citation

Rehab Abdelmonem, et al. Fabrication of Nanostructured Lipid Carriers Ocugel for Enhancing Loratadine Used in Treatment of COVID-19 Related Symptoms: Statistical Optimization, In-vitro, Ex-vivo, and In-vivo Studies Evaluation. Taylor & Francis Group, 2022.